Back
ProQR Therapeutics NV Vs. Pharming Group Industry Stock Comparison
Buy
59
PRQR
ProQR Therapeutics NV
Last Price:
1.98
Seasonality Move:
0.03%
Sell
32
PHAR
Pharming Group
Last Price:
9.76
Seasonality Move:
-4.03%
Buy
59
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $2.01. The Score for PRQR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $9.73. The Score for PHAR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- PHAR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $2.01
The current trend is relatively stagnant and PRQR is experiencing slight selling pressure.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $9.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing slight selling pressure.
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 46.36 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.93 - 2.19) | Sell |
| Bollinger Bands (100): | (1.94 - 2.28) | Sell |
PHAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 43.95 | Sell |
| Chaikin Money Flow: | -470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.77 - 10.71) | Sell |
| Bollinger Bands (100): | (10.46 - 12.28) | Sell |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.98 | Buy |
| 20-day SMA: | 2.04 | Sell |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 1.79 | Buy |
| 8-day EMA: | 1.99 | Buy |
| 20-day EMA: | 2.03 | Sell |
| 50-day EMA: | 2.08 | Sell |
| 200-day EMA: | 1.96 | Buy |
PHAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.01 | Sell |
| 20-day SMA: | 10.11 | Sell |
| 50-day SMA: | 10.74 | Sell |
| 200-day SMA: | 11.69 | Sell |
| 8-day EMA: | 9.97 | Sell |
| 20-day EMA: | 10.15 | Sell |
| 50-day EMA: | 10.64 | Sell |
| 200-day EMA: | 11.4 | Sell |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.25 per share.
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.02 per share.
ProQR Therapeutics NV Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pharming Group Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||